Luigi Bolondi

40.8k total citations · 10 hit papers
278 papers, 18.4k citations indexed

About

Luigi Bolondi is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Luigi Bolondi has authored 278 papers receiving a total of 18.4k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Hepatology, 121 papers in Epidemiology and 69 papers in Surgery. Recurrent topics in Luigi Bolondi's work include Hepatocellular Carcinoma Treatment and Prognosis (133 papers), Liver Disease Diagnosis and Treatment (111 papers) and Liver Disease and Transplantation (102 papers). Luigi Bolondi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (133 papers), Liver Disease Diagnosis and Treatment (111 papers) and Liver Disease and Transplantation (102 papers). Luigi Bolondi collaborates with scholars based in Italy, United States and France. Luigi Bolondi's co-authors include Fabio Piscaglia, Laura Gramantieri, Stefano Gaiani, Rita Golfieri, Jean‐Luc Raoul, Vincenzo Mazzaferro, Alessandro Cucchetti, Gian Luca Grazi, Tito Livraghi and Antonio Daniele Pinna and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Luigi Bolondi

271 papers receiving 18.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

2015 771 citations Luigi Bolondi et al. profile →
Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

1995 713 citations Tito Livraghi, Luigi Bolondi et al. profile →
Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma

2007 670 citations Laura Gramantieri, Manuela Ferracin et al. Cancer Research profile →
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

2012 656 citations Jean‐Luc Raoul, Luigi Bolondi et al. Journal of Hepatology profile →
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

2016 653 citations Luigi Bolondi, S. Brillanti et al. Journal of Hepatology profile →
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations

2006 550 citations Fabio Piscaglia, Luigi Bolondi profile →
Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions

2013 492 citations Fabio Piscaglia, Jean‐Luc Raoul et al. profile →
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma

2014 432 citations Rita Golfieri, Matteo Renzulli et al. profile →
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence

2018 429 citations Jean‐Luc Raoul, Alejandro Forner et al. Cancer Treatment Reviews profile →
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

2010 426 citations Jean‐Luc Raoul, Alejandro Forner et al. Cancer Treatment Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luigi Bolondi Italy	66	12.4k	8.4k	4.1k	3.0k	3.0k	278	18.4k
Fabio Piscaglia Italy	62	15.1k 1.2×	10.7k 1.3×	4.9k 1.2×	2.3k 0.7×	1.8k 0.6×	368	20.9k
Laura Kulik United States	61	15.9k 1.3×	8.4k 1.0×	5.7k 1.4×	2.5k 0.8×	1.9k 0.6×	149	20.1k
Philip J. Johnson United Kingdom	77	11.8k 0.9×	8.6k 1.0×	4.4k 1.1×	3.6k 1.2×	3.5k 1.2×	318	21.8k
Masamichi Kojiro Japan	66	8.3k 0.7×	5.0k 0.6×	4.2k 1.0×	2.6k 0.9×	3.6k 1.2×	281	15.6k
Myron Schwartz United States	77	12.9k 1.0×	6.9k 0.8×	7.4k 1.8×	3.2k 1.1×	3.2k 1.1×	328	20.9k
Alejandro Forner Spain	35	17.4k 1.4×	10.1k 1.2×	4.9k 1.2×	5.0k 1.7×	4.5k 1.5×	120	25.1k
Young Nyun Park South Korea	64	6.8k 0.5×	5.4k 0.6×	3.6k 0.9×	2.1k 0.7×	3.7k 1.2×	391	14.5k
Kwang‐Hyub Han South Korea	72	19.0k 1.5×	16.1k 1.9×	3.5k 0.9×	1.9k 0.6×	1.7k 0.6×	623	24.3k
Bruno Sangro Spain	77	16.2k 1.3×	8.4k 1.0×	4.8k 1.2×	3.5k 1.2×	4.2k 1.4×	416	26.0k
Wan Yee Lau China	65	10.8k 0.9×	5.7k 0.7×	8.0k 2.0×	2.6k 0.9×	1.9k 0.6×	440	19.1k

Countries citing papers authored by Luigi Bolondi

Since Specialization

Citations

This map shows the geographic impact of Luigi Bolondi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Bolondi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Bolondi more than expected).

Fields of papers citing papers by Luigi Bolondi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Bolondi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Bolondi. The network helps show where Luigi Bolondi may publish in the future.

Co-authorship network of co-authors of Luigi Bolondi

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Bolondi. A scholar is included among the top collaborators of Luigi Bolondi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Bolondi. Luigi Bolondi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Renzulli, Matteo, Maurizio Biselli, Stefano Brocchi, et al.. (2018). New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Gut. 67(9). 1674–1682. 118 indexed citations

Raoul, Jean‐Luc, Alejandro Forner, Luigi Bolondi, et al.. (2018). Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. Cancer Treatment Reviews. 72. 28–36. 429 indexed citations breakdown →

Fornari, Francesca, Daniela Pollutri, Clarissa Patrizi, et al.. (2017). In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis. Clinical Cancer Research. 23(14). 3953–3965. 137 indexed citations

Brandi, Giovanni, Francesco De Rosa, Luigi Bolondi, et al.. (2011). Durable complete response of hepatocellular carcinoma after metronomic capecitabine.. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). 96(6). 1028–30. 12 indexed citations

Fornari, Francesca, Maddalena Milazzo, Pasquale Chieco, et al.. (2010). MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. Cancer Research. 70(12). 5184–5193. 343 indexed citations

Fornari, Francesca, Laura Gramantieri, Catia Giovannini, et al.. (2009). MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. Cancer Research. 69(14). 5761–5767. 343 indexed citations

Gramantieri, Laura, Manuela Ferracin, Francesca Fornari, et al.. (2007). Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma. Cancer Research. 67(13). 6092–6099. 670 indexed citations breakdown →

Piscaglia, Fabio, Valeria Camaggi, Matteo Ravaioli, et al.. (2007). A New Priority Policy for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation Within the Model for End-Stage Liver Disease System. Liver Transplantation. 13(6). 857–866. 35 indexed citations

Giovannini, Catia, et al.. (2006). Notch3 intracellular domain accumulates in HepG2 cell line.. PubMed. 26(3A). 2123–7. 30 indexed citations

10.

Bolondi, Luigi, Stefano Gaiani, Natascia Celli, et al.. (2005). Characterization of Small Nodules in Cirrhosis by Assessment of Vascularity: The Problem of Hypovascular Hepatocellular Carcinoma *. Hepatology. 42(1). 27–34. 333 indexed citations

11.

Miotto, Elena, Silvia Sabbioni, Angelo Veronese, et al.. (2004). Frequent Aberrant Methylation of the CDH4 Gene Promoter in Human Colorectal and Gastric Cancer. Cancer Research. 64(22). 8156–8159. 81 indexed citations

12.

Gaiani, Stefano, Laura Volpe, Fabio Piscaglia, & Luigi Bolondi. (2001). Vascularity of liver tumours and recent advances in Doppler ultrasound. Journal of Hepatology. 34(3). 474–482. 37 indexed citations

13.

Sofia, Soccorsa, et al.. (1999). Sonographic findings in abdominal hereditary angioedema. Journal of Clinical Ultrasound. 27(9). 537–540. 4 indexed citations

14.

Gramantieri, Laura, Pasquale Chieco, Fabio Piscaglia, et al.. (1999). Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.. PubMed. 5(11). 3468–75. 18 indexed citations

15.

Livraghi, Tito, Luigi Bolondi, Luigi Buscarini, et al.. (1995). No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Journal of Hepatology. 22(5). 522–526. 211 indexed citations

16.

Siringo, Sebastiano, Luigi Bolondi, Stefano Gaiani, et al.. (1994). Timing of the First Variceal Hemorrhage in Cirrhotic Patients: Prospective Evaluation of Doppler Flowmetry, Endoscopy and Clinical Parameters. Hepatology. 20(1). 66–73. 35 indexed citations

17.

Gaiani, Stefano, Luigi Bolondi, Daphna Fenyves, et al.. (1991). Effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Hepatology. 14(5). 824–829. 39 indexed citations

18.

Bolondi, Luigi, et al.. (1990). Effect of secretin on portal venous flow.. Gut. 31(11). 1306–1310. 12 indexed citations

19.

G, Re, et al.. (1985). Morphological bases of splenic circulation in congestive splenomegaly.. PubMed. 70(4). 283–90. 4 indexed citations

20.

Bolondi, Luigi, Marc Conti, Gianni Plicchi, et al.. (1976). An evaluation of echography in the diagnosis of pancreatic disease.. Gut. 17(3). 228–234. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact